A study of one hospital ICU found significantly higher treatment costs for patients with a central line-associated bloodstream infection than for those without, suggesting hospitals reap substantial profits from such complications, Johns Hopkins researchers reported in the American Journal of Medical Quality. Study researcher and hospital safety expert Dr. Peter Pronovost said hospitals that get windfall profits for treating outlier patients who develop complications have no incentive to implement quality improvement programs to prevent patient harm.
Study finds hospitals profit from patient complications
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan